Mixed Topics
Feature
Time Warp: Fax Machines Still Common in Oncology Practice. Why?
Oncologists are among the many specialists across the country at the mercy of telecopiers.
Latest News
FDA Proposes that Interchangeability Status for Biosimilars Doesn’t Need Switching Studies
The new draft guidance reflects updated scientific thinking on biosimilars, the agency said.
Conference Coverage
Ixekizumab Met Phase 3 Trial Endpoint in Juvenile PsA, Enthesitis-Related Arthritis
Ixekizumab has taken a major step toward its approval for the treatment of psoriatic arthritis and enthesitis-related arthritis in children, based...
Latest News
VEXAS Syndrome: Study Highlights Cutaneous Symptoms
Affected individuals exhibit a wide range of manifestations, including cytopenia/myelodysplasia, multiorgan systemic inflammation, and cutaneous...
Feature
Doctors Endorsing Products on X May Not Disclose Company Ties
Researchers review posts by physicians on X, looking for key words that might indicate that the posts were intended as endorsements of a product...
Feature
Follow-Up Outcomes Data Often Missing for FDA Drug Approvals Based on Surrogate Markers
As the FDA’s use of surrogate endpoints in the drug approval process is increasing, researchers are concerned important postapproval or validation...
Feature
Chatbots Seem More Empathetic Than Docs in Cancer Discussions
AI gives readable, high quality, and empathetic responses to social media queries about cancer.
Feature
Are Direct-to-Consumer Microbiome Tests Clinically Useful?
The lack of reliability has been shown by experts who have tested the tests.
Latest News
Time to Lung Disease in Patients With Dermatomyositis Subtype Estimated
“Establishing an accurate timeline between MDA5 antibody-positive DM and ILD can promote urgency among dermatologists to evaluate extracutaneous...
From the Journals
Cannabis Constituent May Be Key to Easing THC-Induced Anxiety
The findings could have implications for the use of medicinal or recreational cannabis, which has increased in recent years due to state...
Conference Coverage
No Increase in Autoimmune Risk Seen With GLP-1 Receptor Agonists and SGLT2 Inhibitors
Patients with type 2 diabetes prescribed GLP-1 receptor agonists or SGLT2 inhibitors did not have a greater risk of developing autoimmune disease...